|
Name |
N,N,N'-Trimethyl-1,4-benzenediamine
|
Molecular Formula | C9H14N2 | |
IUPAC Name* |
1-N,4-N,4-N-trimethylbenzene-1,4-diamine
|
|
SMILES |
CNC1=CC=C(C=C1)N(C)C
|
|
InChI |
InChI=1S/C9H14N2/c1-10-8-4-6-9(7-5-8)11(2)3/h4-7,10H,1-3H3
|
|
InChIKey |
AWXUBHMURFEJMY-UHFFFAOYSA-N
|
|
Synonyms |
5369-34-6; N,N,N'-Trimethyl-1,4-benzenediamine; N1,N1,N4-trimethylbenzene-1,4-diamine; 1-N,4-N,4-N-trimethylbenzene-1,4-diamine; 1,4-Benzenediamine, N,N,N'-trimethyl-; N,N,N'-Trimethylbenzene-1,4-diamine; SCHEMBL146321; DTXSID50201944; n,n,n'-trimethyl-p-phenylenediamine; ZINC32190450; AKOS008064983; N,N,N'-Trimethyl-1,4-phenylenediamine; N,N,N'-trimethyl-benzene-1,4-diamine; CS-0301381; EN300-66879; A900863; n,n,n'-trimethyl-1,4-benzenediamine dihydrochloride
|
|
CAS | 5369-34-6 | |
PubChem CID | 591595 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 150.22 | ALogp: | 2.0 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 15.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 11 | QED Weighted: | 0.696 |
Caco-2 Permeability: | -4.543 | MDCK Permeability: | 0.00002330 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.949 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.005 |
30% Bioavailability (F30%): | 0.012 |
Blood-Brain-Barrier Penetration (BBB): | 0.974 | Plasma Protein Binding (PPB): | 80.62% |
Volume Distribution (VD): | 1.636 | Fu: | 22.04% |
CYP1A2-inhibitor: | 0.931 | CYP1A2-substrate: | 0.888 |
CYP2C19-inhibitor: | 0.718 | CYP2C19-substrate: | 0.719 |
CYP2C9-inhibitor: | 0.375 | CYP2C9-substrate: | 0.299 |
CYP2D6-inhibitor: | 0.106 | CYP2D6-substrate: | 0.898 |
CYP3A4-inhibitor: | 0.431 | CYP3A4-substrate: | 0.195 |
Clearance (CL): | 9.628 | Half-life (T1/2): | 0.714 |
hERG Blockers: | 0.043 | Human Hepatotoxicity (H-HT): | 0.154 |
Drug-inuced Liver Injury (DILI): | 0.311 | AMES Toxicity: | 0.928 |
Rat Oral Acute Toxicity: | 0.549 | Maximum Recommended Daily Dose: | 0.061 |
Skin Sensitization: | 0.883 | Carcinogencity: | 0.854 |
Eye Corrosion: | 0.773 | Eye Irritation: | 0.993 |
Respiratory Toxicity: | 0.987 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000072 | 0.333 | D0U5QK | 0.333 | ||||
ENC000106 | 0.320 | D08HQK | 0.317 | ||||
ENC000672 | 0.320 | D02WAB | 0.314 | ||||
ENC000233 | 0.300 | D09NYS | 0.299 | ||||
ENC000199 | 0.295 | D02AQY | 0.283 | ||||
ENC000221 | 0.279 | D04VMT | 0.279 | ||||
ENC000086 | 0.268 | D0P8RS | 0.267 | ||||
ENC000152 | 0.265 | D0KD1U | 0.262 | ||||
ENC000222 | 0.261 | D0YQ5L | 0.255 | ||||
ENC000733 | 0.250 | D08GYO | 0.254 |